Forte Biosciences, Inc.
USD21.52
+0.20 (+0.91%)
CEO
Paul A. Wagner
IPO Date
2017-04-13
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$21.29
Prev. Close
$21.32
Day Low
$20.41
Day High
$22.39
52W Low
$9.10
52W High
$35.80
Market Cap
$0.30B
Volume
0.33M
| -1.9 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -89.1% | -80.7% | 0.00 | 10.45 | -0.8 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -35.7% | -33.0% | 0.00 | 13.06 | -1.3 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -52.2% | -50.1% | 0.00 | 24.19 | -1.4 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -78.8% | -75.9% | 0.00 | 26.52 | -5.8 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -70.8% | -53.1% | 0.00 | 3.93 | -4.1 |
| 31 Dec 2018 | FY | 100.0% | -271.4% | -84.2% | -47.5% | 0.45 | 5.91 | -3.4 |
| 31 Dec 2017 | FY | 100.0% | -94948.8% | -54.8% | -42.3% | 0.15 | 5.23 | -3.8 |
| 31 Dec 2016 | FY | 100.0% | -68322.4% | -478.5% | -94.7% | 3.00 | 2.26 | -7.4 |
| -40.5 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -21.0% | -18.2% | 0.00 | 7.34 | -3.8 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -11.4% | -10.4% | 0.00 | 11.74 | -3.4 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -40.7% | -33.0% | 0.00 | 5.22 | -1.4 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -13.6% | -11.6% | 0.00 | 6.76 | -5.1 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -89.6% | -46.8% | 0.00 | 2.06 | -0.3 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -73.8% | -48.0% | 0.00 | 2.82 | -0.5 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -25.9% | -23.2% | 0.00 | 9.45 | -0.9 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -16.6% | -15.1% | 0.00 | 10.45 | -1.3 |